Dhampur Bio Organics543593Tech licensing deal

Technology Licensing Agreement signed with Planetary SA for exclusive Mycoprotein production in India

DBO has entered into a Technology Licensing Agreement with Planetary SA, Switzerland, on October 19, 2026, at 2:30 pm (IST) for the exclusive production of Mycoprotein in India.

By ScoutQuest · Mon 19 Oct 2026, 5:58 PM IST · 3 min read

Royalty: 10% of after-tax revenue, paid quarterly
Initial Term: 10 (ten) years, renewable in blocks of 5 years
Agreement Date: October 19, 2026, at 2:30 pm (IST)

What was signed

DBO has entered into a Technology Licensing Agreement with Planetary SA, Switzerland, on October 19, 2026 at 2:30 pm (IST). The agreement covers the exclusive production of Mycoprotein in India. It follows an earlier non-binding term sheet with Planetary SA.

The agreement sets out the major terms of the arrangement, which the company has summarised in a table.

How the arrangement is structured

Planetary SA, a Switzerland based company, will be the technology provider and the off-taker of the Mycoprotein and related products.
DBO will construct and operate the Mycoprotein production infrastructure and will be the manufacturer and supplier of Mycoprotein and related products.
The parties are to execute a commercialisation and offtake agreement.
The parties are also to execute a joint venture agreement to establish a Joint Venture Company to undertake commercialisation and offtake of Mycoprotein in India.
The manufacture of Mycoprotein using the technology licence will be undertaken in India.
The share exchange ratio / JV ratio is stated as Not Applicable.

What DBO pays

Licensing fee / royalty of 10% of after-tax revenue as defined in the agreement, paid quarterly by DBO to Planetary.
A one-time launch fee for engineering, launch, installation, commissioning, process training and handover support, charged on an open-book basis until completion, as mutually agreed between the parties.
A one-time IT setup fee payable by DBO to Planetary for the configuration of the Data Platform.

Tenure

Unless terminated earlier as per the agreement, it runs for an initial term of 10 (ten) years from the Effective Date. By mutual written agreement, it may be renewed for one or more successive terms of 5 years.

Who does what

Planetary's key obligations: provide licensed intellectual property and specified licensed services; engineering, launch, installation, commissioning and initial training support; maintenance and enforcement of the licensed intellectual property; and agreed technical support, subject to the terms of the agreement.
DBO's key obligations: use the licensed intellectual property only for the project and at the approved facility; pay fees and royalties; comply with confidentiality, access-control, audit, reporting and intellectual-property protection obligations; and obtain the required approvals for its performance.

Why the company says it is doing this

The technology to be used for producing Mycoprotein products has synergy with the existing business and is a forward integration step, in which sugar and molasses will act as feedstock for Mycoprotein production.
By entering into this business, the company says it will introduce a new revenue stream and will be able to increase its profitability.

What a retail investor may want to track

The commercialisation and offtake agreement and the joint venture agreement, which the agreement sets out as steps to be executed between the parties.
The royalty of 10% of after-tax revenue, which links a part of DBO's revenue from this business to payments to Planetary.
The one-time launch fee, charged on an open-book basis until completion as mutually agreed, and the one-time IT setup fee.
The link to the existing sugar and molasses business as feedstock, which is the stated rationale for the deal.
The arrangement does not involve any related party transaction.

Also from Dhampur Bio Organics